nodes	percent_of_prediction	percent_of_DWPC	metapath
Flecainide—Hemiparesis—Temozolomide—malignant glioma	0.0473	0.0524	CcSEcCtD
Flecainide—Mefloquine—BCHE—malignant glioma	0.0318	1	CrCbGaD
Flecainide—Paresis—Temozolomide—malignant glioma	0.0271	0.0301	CcSEcCtD
Flecainide—Paranoid reaction—Carmustine—malignant glioma	0.0241	0.0267	CcSEcCtD
Flecainide—Pulmonary fibrosis—Carmustine—malignant glioma	0.0233	0.0259	CcSEcCtD
Flecainide—Pulmonary fibrosis—Temozolomide—malignant glioma	0.0225	0.025	CcSEcCtD
Flecainide—Lung infiltration—Carmustine—malignant glioma	0.0219	0.0243	CcSEcCtD
Flecainide—Parosmia—Temozolomide—malignant glioma	0.0153	0.0169	CcSEcCtD
Flecainide—Paranoia—Carmustine—malignant glioma	0.015	0.0167	CcSEcCtD
Flecainide—Digestion impaired—Temozolomide—malignant glioma	0.0148	0.0164	CcSEcCtD
Flecainide—Interstitial lung disease—Carmustine—malignant glioma	0.0145	0.0161	CcSEcCtD
Flecainide—Interstitial lung disease—Temozolomide—malignant glioma	0.014	0.0155	CcSEcCtD
Flecainide—Apathy—Temozolomide—malignant glioma	0.0139	0.0154	CcSEcCtD
Flecainide—Flat affect—Temozolomide—malignant glioma	0.0137	0.0152	CcSEcCtD
Flecainide—Stupor—Carmustine—malignant glioma	0.0137	0.0152	CcSEcCtD
Flecainide—Scotoma—Carmustine—malignant glioma	0.0135	0.015	CcSEcCtD
Flecainide—Cholestasis—Temozolomide—malignant glioma	0.013	0.0145	CcSEcCtD
Flecainide—Scotoma—Temozolomide—malignant glioma	0.013	0.0145	CcSEcCtD
Flecainide—Speech disorder—Carmustine—malignant glioma	0.0119	0.0132	CcSEcCtD
Flecainide—Speech disorder—Temozolomide—malignant glioma	0.0115	0.0128	CcSEcCtD
Flecainide—Depressed level of consciousness—Carmustine—malignant glioma	0.0099	0.011	CcSEcCtD
Flecainide—Neuropathy—Carmustine—malignant glioma	0.00962	0.0107	CcSEcCtD
Flecainide—Depressed level of consciousness—Temozolomide—malignant glioma	0.00956	0.0106	CcSEcCtD
Flecainide—Coma—Carmustine—malignant glioma	0.00937	0.0104	CcSEcCtD
Flecainide—Neuropathy—Temozolomide—malignant glioma	0.0093	0.0103	CcSEcCtD
Flecainide—Gynaecomastia—Carmustine—malignant glioma	0.00917	0.0102	CcSEcCtD
Flecainide—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00827	0.00917	CcSEcCtD
Flecainide—Eye pain—Carmustine—malignant glioma	0.00824	0.00914	CcSEcCtD
Flecainide—Deafness—Temozolomide—malignant glioma	0.00804	0.00892	CcSEcCtD
Flecainide—Hepatic failure—Temozolomide—malignant glioma	0.008	0.00888	CcSEcCtD
Flecainide—Eye pain—Temozolomide—malignant glioma	0.00796	0.00884	CcSEcCtD
Flecainide—Amnesia—Carmustine—malignant glioma	0.00792	0.00879	CcSEcCtD
Flecainide—Amnesia—Temozolomide—malignant glioma	0.00765	0.00849	CcSEcCtD
Flecainide—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00762	0.00845	CcSEcCtD
Flecainide—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00744	0.00825	CcSEcCtD
Flecainide—Diplopia—Carmustine—malignant glioma	0.00744	0.00825	CcSEcCtD
Flecainide—Diplopia—Temozolomide—malignant glioma	0.00719	0.00798	CcSEcCtD
Flecainide—Ataxia—Carmustine—malignant glioma	0.007	0.00776	CcSEcCtD
Flecainide—Ataxia—Temozolomide—malignant glioma	0.00676	0.0075	CcSEcCtD
Flecainide—Sweating increased—Temozolomide—malignant glioma	0.00605	0.00672	CcSEcCtD
Flecainide—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—COX8A—malignant glioma	0.0059	0.0883	CbGpPWpGaD
Flecainide—Dysuria—Temozolomide—malignant glioma	0.00581	0.00645	CcSEcCtD
Flecainide—Hyperglycaemia—Carmustine—malignant glioma	0.0058	0.00644	CcSEcCtD
Flecainide—Pneumonia—Carmustine—malignant glioma	0.00577	0.0064	CcSEcCtD
Flecainide—Erectile dysfunction—Temozolomide—malignant glioma	0.00572	0.00635	CcSEcCtD
Flecainide—Photosensitivity reaction—Temozolomide—malignant glioma	0.00567	0.00629	CcSEcCtD
Flecainide—Renal failure—Carmustine—malignant glioma	0.00564	0.00625	CcSEcCtD
Flecainide—Neuropathy peripheral—Carmustine—malignant glioma	0.00562	0.00624	CcSEcCtD
Flecainide—Hyperglycaemia—Temozolomide—malignant glioma	0.00561	0.00622	CcSEcCtD
Flecainide—Pneumonia—Temozolomide—malignant glioma	0.00557	0.00618	CcSEcCtD
Flecainide—Neuropathy peripheral—Temozolomide—malignant glioma	0.00543	0.00603	CcSEcCtD
Flecainide—Hypoaesthesia—Carmustine—malignant glioma	0.00512	0.00568	CcSEcCtD
Flecainide—Hallucination—Carmustine—malignant glioma	0.00512	0.00568	CcSEcCtD
Flecainide—Visual impairment—Carmustine—malignant glioma	0.00496	0.0055	CcSEcCtD
Flecainide—Hypoaesthesia—Temozolomide—malignant glioma	0.00495	0.00549	CcSEcCtD
Flecainide—Hallucination—Temozolomide—malignant glioma	0.00495	0.00549	CcSEcCtD
Flecainide—Eye disorder—Carmustine—malignant glioma	0.00481	0.00534	CcSEcCtD
Flecainide—Visual impairment—Temozolomide—malignant glioma	0.00479	0.00532	CcSEcCtD
Flecainide—Flushing—Carmustine—malignant glioma	0.00478	0.0053	CcSEcCtD
Flecainide—Eye disorder—Temozolomide—malignant glioma	0.00465	0.00516	CcSEcCtD
Flecainide—Tinnitus—Temozolomide—malignant glioma	0.00464	0.00515	CcSEcCtD
Flecainide—Flushing—Temozolomide—malignant glioma	0.00462	0.00512	CcSEcCtD
Flecainide—Alopecia—Carmustine—malignant glioma	0.00455	0.00505	CcSEcCtD
Flecainide—Immune system disorder—Temozolomide—malignant glioma	0.00449	0.00498	CcSEcCtD
Flecainide—Alopecia—Temozolomide—malignant glioma	0.0044	0.00488	CcSEcCtD
Flecainide—Dysgeusia—Temozolomide—malignant glioma	0.00424	0.0047	CcSEcCtD
Flecainide—Vision blurred—Carmustine—malignant glioma	0.00422	0.00468	CcSEcCtD
Flecainide—Tremor—Carmustine—malignant glioma	0.0042	0.00466	CcSEcCtD
Flecainide—Vision blurred—Temozolomide—malignant glioma	0.00408	0.00453	CcSEcCtD
Flecainide—Tremor—Temozolomide—malignant glioma	0.00406	0.0045	CcSEcCtD
Flecainide—Ill-defined disorder—Temozolomide—malignant glioma	0.00402	0.00446	CcSEcCtD
Flecainide—Leukopenia—Carmustine—malignant glioma	0.00401	0.00445	CcSEcCtD
Flecainide—Malaise—Temozolomide—malignant glioma	0.0039	0.00433	CcSEcCtD
Flecainide—Vertigo—Temozolomide—malignant glioma	0.00389	0.00432	CcSEcCtD
Flecainide—Convulsion—Carmustine—malignant glioma	0.00388	0.00431	CcSEcCtD
Flecainide—Leukopenia—Temozolomide—malignant glioma	0.00388	0.0043	CcSEcCtD
Flecainide—Hypertension—Carmustine—malignant glioma	0.00387	0.00429	CcSEcCtD
Flecainide—Palpitations—Temozolomide—malignant glioma	0.00383	0.00425	CcSEcCtD
Flecainide—Chest pain—Carmustine—malignant glioma	0.00381	0.00423	CcSEcCtD
Flecainide—Myalgia—Carmustine—malignant glioma	0.00381	0.00423	CcSEcCtD
Flecainide—Anxiety—Carmustine—malignant glioma	0.0038	0.00422	CcSEcCtD
Flecainide—Cough—Temozolomide—malignant glioma	0.00378	0.00419	CcSEcCtD
Flecainide—Convulsion—Temozolomide—malignant glioma	0.00375	0.00416	CcSEcCtD
Flecainide—Hypertension—Temozolomide—malignant glioma	0.00374	0.00415	CcSEcCtD
Flecainide—Confusional state—Carmustine—malignant glioma	0.00369	0.00409	CcSEcCtD
Flecainide—Myalgia—Temozolomide—malignant glioma	0.00369	0.00409	CcSEcCtD
Flecainide—Arthralgia—Temozolomide—malignant glioma	0.00369	0.00409	CcSEcCtD
Flecainide—Anxiety—Temozolomide—malignant glioma	0.00367	0.00408	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00366	0.00406	CcSEcCtD
Flecainide—Oedema—Carmustine—malignant glioma	0.00366	0.00406	CcSEcCtD
Flecainide—Discomfort—Temozolomide—malignant glioma	0.00364	0.00404	CcSEcCtD
Flecainide—Dry mouth—Temozolomide—malignant glioma	0.00361	0.004	CcSEcCtD
Flecainide—Thrombocytopenia—Carmustine—malignant glioma	0.00358	0.00397	CcSEcCtD
Flecainide—Tachycardia—Carmustine—malignant glioma	0.00357	0.00396	CcSEcCtD
Flecainide—Confusional state—Temozolomide—malignant glioma	0.00356	0.00395	CcSEcCtD
Flecainide—Oedema—Temozolomide—malignant glioma	0.00353	0.00392	CcSEcCtD
Flecainide—Anorexia—Carmustine—malignant glioma	0.00349	0.00387	CcSEcCtD
Flecainide—Nervous system disorder—Temozolomide—malignant glioma	0.00347	0.00384	CcSEcCtD
Flecainide—Thrombocytopenia—Temozolomide—malignant glioma	0.00346	0.00384	CcSEcCtD
Flecainide—Skin disorder—Temozolomide—malignant glioma	0.00343	0.00381	CcSEcCtD
Flecainide—Hypotension—Carmustine—malignant glioma	0.00342	0.00379	CcSEcCtD
Flecainide—Hyperhidrosis—Temozolomide—malignant glioma	0.00342	0.00379	CcSEcCtD
Flecainide—Anorexia—Temozolomide—malignant glioma	0.00337	0.00374	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00333	0.0037	CcSEcCtD
Flecainide—Insomnia—Carmustine—malignant glioma	0.00331	0.00367	CcSEcCtD
Flecainide—Paraesthesia—Carmustine—malignant glioma	0.00328	0.00364	CcSEcCtD
Flecainide—Dyspnoea—Carmustine—malignant glioma	0.00326	0.00362	CcSEcCtD
Flecainide—Somnolence—Carmustine—malignant glioma	0.00325	0.00361	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00322	0.00357	CcSEcCtD
Flecainide—Insomnia—Temozolomide—malignant glioma	0.0032	0.00355	CcSEcCtD
Flecainide—Decreased appetite—Carmustine—malignant glioma	0.00318	0.00353	CcSEcCtD
Flecainide—Paraesthesia—Temozolomide—malignant glioma	0.00317	0.00352	CcSEcCtD
Flecainide—Gastrointestinal disorder—Carmustine—malignant glioma	0.00316	0.0035	CcSEcCtD
Flecainide—Dyspnoea—Temozolomide—malignant glioma	0.00315	0.0035	CcSEcCtD
Flecainide—Somnolence—Temozolomide—malignant glioma	0.00314	0.00349	CcSEcCtD
Flecainide—Constipation—Carmustine—malignant glioma	0.00313	0.00347	CcSEcCtD
Flecainide—Pain—Carmustine—malignant glioma	0.00313	0.00347	CcSEcCtD
Flecainide—Dyspepsia—Temozolomide—malignant glioma	0.00311	0.00345	CcSEcCtD
Flecainide—Decreased appetite—Temozolomide—malignant glioma	0.00307	0.00341	CcSEcCtD
Flecainide—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00305	0.00338	CcSEcCtD
Flecainide—Fatigue—Temozolomide—malignant glioma	0.00305	0.00338	CcSEcCtD
Flecainide—Pain—Temozolomide—malignant glioma	0.00302	0.00335	CcSEcCtD
Flecainide—Constipation—Temozolomide—malignant glioma	0.00302	0.00335	CcSEcCtD
Flecainide—Feeling abnormal—Carmustine—malignant glioma	0.00301	0.00334	CcSEcCtD
Flecainide—Gastrointestinal pain—Carmustine—malignant glioma	0.00299	0.00332	CcSEcCtD
Flecainide—Feeling abnormal—Temozolomide—malignant glioma	0.00291	0.00323	CcSEcCtD
Flecainide—Body temperature increased—Carmustine—malignant glioma	0.00289	0.00321	CcSEcCtD
Flecainide—Abdominal pain—Carmustine—malignant glioma	0.00289	0.00321	CcSEcCtD
Flecainide—Gastrointestinal pain—Temozolomide—malignant glioma	0.00289	0.00321	CcSEcCtD
Flecainide—Urticaria—Temozolomide—malignant glioma	0.00281	0.00311	CcSEcCtD
Flecainide—Body temperature increased—Temozolomide—malignant glioma	0.00279	0.0031	CcSEcCtD
Flecainide—Abdominal pain—Temozolomide—malignant glioma	0.00279	0.0031	CcSEcCtD
Flecainide—Asthenia—Carmustine—malignant glioma	0.00262	0.00291	CcSEcCtD
Flecainide—Asthenia—Temozolomide—malignant glioma	0.00254	0.00281	CcSEcCtD
Flecainide—CYP2D6—CYP2E1 reactions—CYP2B6—malignant glioma	0.00251	0.0376	CbGpPWpGaD
Flecainide—Diarrhoea—Carmustine—malignant glioma	0.0025	0.00278	CcSEcCtD
Flecainide—Pruritus—Temozolomide—malignant glioma	0.0025	0.00277	CcSEcCtD
Flecainide—CYP2C9—CYP2E1 reactions—CYP2B6—malignant glioma	0.00249	0.0372	CbGpPWpGaD
Flecainide—Dizziness—Carmustine—malignant glioma	0.00242	0.00268	CcSEcCtD
Flecainide—Diarrhoea—Temozolomide—malignant glioma	0.00242	0.00268	CcSEcCtD
Flecainide—Dizziness—Temozolomide—malignant glioma	0.00234	0.00259	CcSEcCtD
Flecainide—Vomiting—Carmustine—malignant glioma	0.00232	0.00258	CcSEcCtD
Flecainide—Rash—Carmustine—malignant glioma	0.00231	0.00256	CcSEcCtD
Flecainide—Dermatitis—Carmustine—malignant glioma	0.0023	0.00256	CcSEcCtD
Flecainide—Headache—Carmustine—malignant glioma	0.00229	0.00254	CcSEcCtD
Flecainide—Vomiting—Temozolomide—malignant glioma	0.00225	0.00249	CcSEcCtD
Flecainide—Rash—Temozolomide—malignant glioma	0.00223	0.00247	CcSEcCtD
Flecainide—Dermatitis—Temozolomide—malignant glioma	0.00223	0.00247	CcSEcCtD
Flecainide—Headache—Temozolomide—malignant glioma	0.00221	0.00246	CcSEcCtD
Flecainide—Nausea—Carmustine—malignant glioma	0.00217	0.00241	CcSEcCtD
Flecainide—Nausea—Temozolomide—malignant glioma	0.0021	0.00233	CcSEcCtD
Flecainide—CYP2D6—Fatty acids—CYP2B6—malignant glioma	0.00196	0.0293	CbGpPWpGaD
Flecainide—SCN5A—Cardiac Progenitor Differentiation—SOX2—malignant glioma	0.00185	0.0276	CbGpPWpGaD
Flecainide—CYP2D6—Oxidation by Cytochrome P450—POR—malignant glioma	0.00183	0.0274	CbGpPWpGaD
Flecainide—CYP2C9—Oxidation by Cytochrome P450—POR—malignant glioma	0.00182	0.0272	CbGpPWpGaD
Flecainide—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—malignant glioma	0.00174	0.026	CbGpPWpGaD
Flecainide—CYP2D6—Xenobiotics—CYP2B6—malignant glioma	0.00156	0.0233	CbGpPWpGaD
Flecainide—CYP2C9—Xenobiotics—CYP2B6—malignant glioma	0.00154	0.0231	CbGpPWpGaD
Flecainide—CYP2D6—Xenobiotics—CYP2C18—malignant glioma	0.00135	0.0202	CbGpPWpGaD
Flecainide—CYP2C9—Xenobiotics—CYP2C18—malignant glioma	0.00134	0.02	CbGpPWpGaD
Flecainide—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.00106	0.0159	CbGpPWpGaD
Flecainide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.00101	0.0151	CbGpPWpGaD
Flecainide—SCN5A—Cardiac Progenitor Differentiation—PDGFRA—malignant glioma	0.000981	0.0147	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—RUNX3—malignant glioma	0.000874	0.0131	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—GDNF—malignant glioma	0.000845	0.0126	CbGpPWpGaD
Flecainide—SCN5A—Cardiac Progenitor Differentiation—KDR—malignant glioma	0.000826	0.0123	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—MYB—malignant glioma	0.000807	0.0121	CbGpPWpGaD
Flecainide—SCN4A—L1CAM interactions—FGFR1—malignant glioma	0.000804	0.012	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—SOX2—malignant glioma	0.000779	0.0117	CbGpPWpGaD
Flecainide—SCN5A—Cardiac Progenitor Differentiation—NOTCH1—malignant glioma	0.000778	0.0116	CbGpPWpGaD
Flecainide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000647	0.00967	CbGpPWpGaD
Flecainide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000641	0.00959	CbGpPWpGaD
Flecainide—SCN5A—Cardiac Progenitor Differentiation—FGF2—malignant glioma	0.00064	0.00957	CbGpPWpGaD
Flecainide—CYP2D6—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000638	0.00954	CbGpPWpGaD
Flecainide—CYP2C9—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000633	0.00946	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—YWHAE—malignant glioma	0.000606	0.00906	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—NTRK2—malignant glioma	0.000606	0.00906	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—GDNF—malignant glioma	0.000603	0.00902	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—GDNF—malignant glioma	0.000573	0.00857	CbGpPWpGaD
Flecainide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000561	0.00838	CbGpPWpGaD
Flecainide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000556	0.00831	CbGpPWpGaD
Flecainide—CYP2D6—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000553	0.00827	CbGpPWpGaD
Flecainide—CYP2C9—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000548	0.0082	CbGpPWpGaD
Flecainide—SCN5A—L1CAM interactions—FGFR1—malignant glioma	0.000545	0.00815	CbGpPWpGaD
Flecainide—CYP2D6—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000524	0.00784	CbGpPWpGaD
Flecainide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.00052	0.00777	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—GJA1—malignant glioma	0.000498	0.00745	CbGpPWpGaD
Flecainide—CYP2C9—Arachidonic acid metabolism—PTGS1—malignant glioma	0.000487	0.00729	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—SOX2—malignant glioma	0.000457	0.00684	CbGpPWpGaD
Flecainide—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000454	0.0068	CbGpPWpGaD
Flecainide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000451	0.00674	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—HES1—malignant glioma	0.000434	0.0065	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—GDNF—malignant glioma	0.000409	0.00612	CbGpPWpGaD
Flecainide—SCN4A—L1CAM interactions—EGFR—malignant glioma	0.000375	0.00561	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.000364	0.00544	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—PTK2—malignant glioma	0.000363	0.00544	CbGpPWpGaD
Flecainide—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000344	0.00515	CbGpPWpGaD
Flecainide—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000341	0.00511	CbGpPWpGaD
Flecainide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000323	0.00483	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—SOX2—malignant glioma	0.00031	0.00463	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—FGFR1—malignant glioma	0.000304	0.00454	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—KDR—malignant glioma	0.000286	0.00428	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—MET—malignant glioma	0.00028	0.00419	CbGpPWpGaD
Flecainide—CYP2D6—Biological oxidations—CYP2B6—malignant glioma	0.000278	0.00416	CbGpPWpGaD
Flecainide—CYP2C9—Biological oxidations—CYP2B6—malignant glioma	0.000276	0.00413	CbGpPWpGaD
Flecainide—CYP2D6—Metapathway biotransformation—CYP2B6—malignant glioma	0.000275	0.00411	CbGpPWpGaD
Flecainide—CYP2C9—Metapathway biotransformation—CYP2B6—malignant glioma	0.000272	0.00407	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—PTK2—malignant glioma	0.000259	0.00388	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—PTPN11—malignant glioma	0.000259	0.00387	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—HES1—malignant glioma	0.000255	0.00381	CbGpPWpGaD
Flecainide—SCN5A—L1CAM interactions—EGFR—malignant glioma	0.000254	0.00381	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—NCOR1—malignant glioma	0.000253	0.00379	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—PTK2—malignant glioma	0.000246	0.00368	CbGpPWpGaD
Flecainide—CYP2D6—Biological oxidations—CYP2C18—malignant glioma	0.000241	0.00361	CbGpPWpGaD
Flecainide—CYP2C9—Biological oxidations—CYP2C18—malignant glioma	0.000239	0.00358	CbGpPWpGaD
Flecainide—CYP2D6—Metapathway biotransformation—CYP2C18—malignant glioma	0.000238	0.00356	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000236	0.00353	CbGpPWpGaD
Flecainide—CYP2C9—Metapathway biotransformation—CYP2C18—malignant glioma	0.000236	0.00353	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—MMP2—malignant glioma	0.000234	0.00349	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000226	0.00339	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000226	0.00338	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—FGFR1—malignant glioma	0.000217	0.00324	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—RAF1—malignant glioma	0.000207	0.00309	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—FGFR1—malignant glioma	0.000206	0.00308	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—ERBB2—malignant glioma	0.000205	0.00306	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—KDR—malignant glioma	0.000204	0.00305	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—MET—malignant glioma	0.0002	0.00299	CbGpPWpGaD
Flecainide—CYP2D6—Biological oxidations—GSTT1—malignant glioma	0.000195	0.00292	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—KDR—malignant glioma	0.000194	0.0029	CbGpPWpGaD
Flecainide—CYP2C9—Biological oxidations—GSTT1—malignant glioma	0.000194	0.00289	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—NOTCH1—malignant glioma	0.000192	0.00288	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000192	0.00287	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—MET—malignant glioma	0.00019	0.00284	CbGpPWpGaD
Flecainide—CYP2C9—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000187	0.00279	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—PTPN11—malignant glioma	0.000185	0.00276	CbGpPWpGaD
Flecainide—CYP2D6—Biological oxidations—PTGS1—malignant glioma	0.000183	0.00274	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—PPARG—malignant glioma	0.000182	0.00271	CbGpPWpGaD
Flecainide—CYP2C9—Biological oxidations—PTGS1—malignant glioma	0.000181	0.00271	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—PTK2—malignant glioma	0.000176	0.00263	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—MMP9—malignant glioma	0.000176	0.00263	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—PTPN11—malignant glioma	0.000176	0.00263	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—HES1—malignant glioma	0.000173	0.00258	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—AKT2—malignant glioma	0.000172	0.00257	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—NCOR1—malignant glioma	0.000172	0.00257	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—MMP2—malignant glioma	0.000167	0.00249	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000164	0.00246	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—MMP2—malignant glioma	0.000158	0.00237	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—FGF2—malignant glioma	0.000158	0.00237	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—VEGFA—malignant glioma	0.000158	0.00236	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—RAF1—malignant glioma	0.000148	0.00221	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—FGFR1—malignant glioma	0.000147	0.0022	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—ERBB2—malignant glioma	0.000146	0.00218	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—EGFR—malignant glioma	0.000142	0.00212	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—RAF1—malignant glioma	0.00014	0.0021	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—ERBB2—malignant glioma	0.000139	0.00207	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—KDR—malignant glioma	0.000138	0.00207	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—RTEL1—malignant glioma	0.000137	0.00205	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—RTEL1—malignant glioma	0.000136	0.00203	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—MET—malignant glioma	0.000135	0.00203	CbGpPWpGaD
Flecainide—CYP2D6—Biological oxidations—GSTP1—malignant glioma	0.000135	0.00202	CbGpPWpGaD
Flecainide—CYP2C9—Biological oxidations—GSTP1—malignant glioma	0.000134	0.00201	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—KRAS—malignant glioma	0.000134	0.002	CbGpPWpGaD
Flecainide—CYP2D6—Metapathway biotransformation—GSTP1—malignant glioma	0.000133	0.002	CbGpPWpGaD
Flecainide—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	0.000132	0.00198	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—NOTCH1—malignant glioma	0.00013	0.00195	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—MMP9—malignant glioma	0.000125	0.00187	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—PTPN11—malignant glioma	0.000125	0.00187	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—PPARG—malignant glioma	0.000123	0.00184	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—MMP9—malignant glioma	0.000119	0.00178	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—AKT2—malignant glioma	0.000117	0.00174	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—MMP2—malignant glioma	0.000113	0.00169	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—VEGFA—malignant glioma	0.000112	0.00168	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—STAT3—malignant glioma	0.000111	0.00167	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—FGF2—malignant glioma	0.000107	0.00161	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—VEGFA—malignant glioma	0.000107	0.0016	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—EGFR—malignant glioma	0.000101	0.00151	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—RAF1—malignant glioma	0.0001	0.0015	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—ERBB2—malignant glioma	9.9e-05	0.00148	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	9.69e-05	0.00145	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—TNF—malignant glioma	9.64e-05	0.00144	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—EGFR—malignant glioma	9.62e-05	0.00144	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—KRAS—malignant glioma	9.56e-05	0.00143	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	9.38e-05	0.0014	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—KRAS—malignant glioma	9.08e-05	0.00136	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—MMP9—malignant glioma	8.49e-05	0.00127	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—COX8A—malignant glioma	7.86e-05	0.00118	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—COX8A—malignant glioma	7.79e-05	0.00117	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—VEGFA—malignant glioma	7.63e-05	0.00114	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—STAT3—malignant glioma	7.55e-05	0.00113	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—AKT1—malignant glioma	7.18e-05	0.00107	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	6.96e-05	0.00104	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—EGFR—malignant glioma	6.86e-05	0.00103	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ASMT—malignant glioma	6.68e-05	0.000999	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ASMT—malignant glioma	6.62e-05	0.000991	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—TNF—malignant glioma	6.54e-05	0.000977	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—KRAS—malignant glioma	6.48e-05	0.00097	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	6.48e-05	0.000968	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—BCAN—malignant glioma	6.28e-05	0.00094	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—BCAN—malignant glioma	6.23e-05	0.000932	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—IDH2—malignant glioma	5.06e-05	0.000757	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—IDH2—malignant glioma	5.02e-05	0.000751	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—AKT1—malignant glioma	4.87e-05	0.000728	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CYP2B6—malignant glioma	4.76e-05	0.000712	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.73e-05	0.000708	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP2B6—malignant glioma	4.72e-05	0.000706	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—IDH1—malignant glioma	4.36e-05	0.000651	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—IDH1—malignant glioma	4.32e-05	0.000646	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SPHK1—malignant glioma	4.21e-05	0.00063	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SPHK1—malignant glioma	4.18e-05	0.000625	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CYP2C18—malignant glioma	4.13e-05	0.000617	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP2C18—malignant glioma	4.09e-05	0.000612	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.86e-05	0.000577	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.52e-05	0.000526	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.39e-05	0.000507	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GSTT1—malignant glioma	3.34e-05	0.000499	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GSTT1—malignant glioma	3.31e-05	0.000495	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PTGS1—malignant glioma	3.13e-05	0.000468	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PTGS1—malignant glioma	3.1e-05	0.000464	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.09e-05	0.000462	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—BCHE—malignant glioma	2.91e-05	0.000435	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—BCHE—malignant glioma	2.88e-05	0.000431	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SLC5A5—malignant glioma	2.87e-05	0.00043	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SLC5A5—malignant glioma	2.85e-05	0.000426	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.69e-05	0.000403	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.67e-05	0.000399	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.33e-05	0.000348	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GSTP1—malignant glioma	2.31e-05	0.000346	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GSTP1—malignant glioma	2.29e-05	0.000343	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CAT—malignant glioma	2.25e-05	0.000337	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CAT—malignant glioma	2.23e-05	0.000334	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—NCOR1—malignant glioma	2.13e-05	0.000318	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—NCOR1—malignant glioma	2.11e-05	0.000315	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CAV1—malignant glioma	1.73e-05	0.000259	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CAV1—malignant glioma	1.72e-05	0.000257	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.64e-05	0.000246	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PIK3CG—malignant glioma	1.58e-05	0.000236	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PIK3CG—malignant glioma	1.57e-05	0.000234	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PPARG—malignant glioma	1.52e-05	0.000228	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PPARG—malignant glioma	1.51e-05	0.000226	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PIK3CD—malignant glioma	1.39e-05	0.000208	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PIK3CD—malignant glioma	1.38e-05	0.000206	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PIK3CB—malignant glioma	1.21e-05	0.000181	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PIK3CB—malignant glioma	1.2e-05	0.000179	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PTGS2—malignant glioma	1.2e-05	0.000179	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PTGS2—malignant glioma	1.19e-05	0.000178	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PTEN—malignant glioma	1.05e-05	0.000156	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PTEN—malignant glioma	1.04e-05	0.000155	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PIK3CA—malignant glioma	7.38e-06	0.00011	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PIK3CA—malignant glioma	7.31e-06	0.000109	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—AKT1—malignant glioma	6.03e-06	9.01e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—AKT1—malignant glioma	5.97e-06	8.94e-05	CbGpPWpGaD
